Stopping immunomodulatory medications in MS: Frequency, reasons and consequences

W. O. Tobin, B. G. Weinshenker

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Prolonged periods of disease quiescence during long term treatment of patients with clinically isolated syndrome and MS may prompt consideration of discontinuing disease-modifying therapy (DMT). We reviewed pertinent studies to identify the frequency and reasons for discontinuation of DMT.

Original languageEnglish (US)
Pages (from-to)437-443
Number of pages7
JournalMultiple Sclerosis and Related Disorders
Issue number5
StatePublished - Sep 1 2015


  • Disease activity
  • Multiple sclerosis
  • Treatment discontinuation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Stopping immunomodulatory medications in MS: Frequency, reasons and consequences'. Together they form a unique fingerprint.

Cite this